Takeda Revenue and Competitors
Estimated Revenue & Valuation
- Takeda's estimated annual revenue is currently $200.6M per year.
- Takeda's estimated revenue per employee is $195,324
- Takeda's current valuation is $45.9B. (January 2022)
Employee Data
- Takeda has 1027 Employees.
- Takeda grew their employee count by 5% last year.
Takeda's People
Name | Title | Email/Phone |
---|---|---|
1 | Assistant to CFO | Reveal Email/Phone |
2 | Head R&D E&C Programs & Strategy, R&D Ethics & Compliance, TAKEDA PHARMACEUTICALS | Reveal Email/Phone |
3 | VP, Head, R&D Business Operations | Reveal Email/Phone |
4 | Head Epidemiology (Vaccines BU) | Reveal Email/Phone |
5 | Sr. Director, Head Device & Combination Products Quality Organization Global Takeda | Reveal Email/Phone |
6 | Senior Director, Toxicology, DSRE Therapeutic Area Lead- Oncology | Reveal Email/Phone |
7 | Scientist (Associate Director Level) | Reveal Email/Phone |
8 | Director Digital Enablement | Reveal Email/Phone |
9 | Medical Director, Clinical and Translational Sciences | Reveal Email/Phone |
10 | Senior Director - Procurement Lead Direct Materials (Raw & Pack) & Japan GMS Procurement Lead | Reveal Email/Phone |
Takeda Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.1M | 65 | 30% | N/A | N/A |
#2 | $75.6M | 376 | 7% | N/A | N/A |
#3 | $23.9M | 124 | 25% | $35M | N/A |
#4 | $12.7M | 63 | -3% | N/A | N/A |
#5 | $5.4M | 27 | -25% | N/A | N/A |
#6 | $6M | 30 | -35% | N/A | N/A |
#7 | $6.6M | 33 | -8% | N/A | N/A |
#8 | $13.5M | 67 | -3% | N/A | N/A |
#9 | $186.3M | 927 | 19% | N/A | N/A |
#10 | $4.4M | 22 | -4% | N/A | N/A |
What Is Takeda?
In1781,Chobei Takeda I begins selling traditional Japanese and Chinese herbal medicines in Doshomachi , the medicine district of Osaka, Japan. Takeda’s founder gains a reputation for business integrity and quality products and services. These characteristics and values continue through the years and become embeded into our uncompromising corporate philosophy, which still guide us today.
keywords:N/AN/A
Total Funding
1027
Number of Employees
$200.6M
Revenue (est)
5%
Employee Growth %
$45.9B
Valuation
N/A
Accelerator
Takeda News
... ? The ouster of former Immunomedics exec Usama Malik created a CEO opening at Fore Biotherapeutics, which is taking aim at BRAF...
These data announcements follow completion of patient enrollment in Takeda's AURORA (TAK-620-302) study, focusing on LIVTENCITY for first-line...
These data announcements follow completion of patient enrollment in Takeda's AURORA (TAK-620-302) study, focusing on LIVTENCITY for first-line...
... ? The ouster of former Immunomedics exec Usama Malik created a CEO opening at Fore Biotherapeutics, which is taking aim at BRAF...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $384.5M | 1149 | 8% | N/A |
#2 | $201.6M | 1200 | 2% | N/A |
#3 | $312.5M | 1240 | N/A | N/A |
#4 | $268.9M | 1338 | 8% | N/A |
#5 | $300M | 1563 | 6% | N/A |